ExodusPoint Capital Management’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
Other funds holding TYRA
SL
ExodusPoint Capital Management's TYRA Position: Q3 2026 in Review
ExodusPoint Capital Management sold out of Tyra Biosciences (TYRA) in Q3 2026, closing a stake of 41,026 shares — an estimated $1.31M sold.
ExodusPoint Capital Management first reported a position in TYRA in Q1 2024 and held it in 7 quarters. The position peaked at $4.46M in Q1 2024. 155 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.
- ExodusPoint Capital Management reported no remaining Tyra Biosciences position as of Q3 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 41,026 Tyra Biosciences shares in Q3 2026, an estimated $1.31M.
- ExodusPoint Capital Management first reported a position in Tyra Biosciences in Q1 2024 and held it in 7 quarters.
- ExodusPoint Capital Management's Tyra Biosciences position peaked at $4.46M in Q1 2024.
- 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.